Select Medical Holdings Corp
NYSE:SEM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11.77
20.38
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Select Medical Holdings Corp
Select Medical Holdings Corp. operates in a nuanced and complex healthcare environment, transforming the landscape of rehabilitation and critical illness recovery. Founded in 1996, the company embarked on its journey with a vision to bridge gaps in post-acute care, establishing a network that today includes long-term acute care hospitals, inpatient rehabilitation facilities, and outpatient clinics. This vast network caters to individuals requiring extended medical care, rehabilitation, or therapy following serious illnesses or injuries. The company's operational model revolves around specialized healthcare services, offering a continuum of care that supports patient recovery from severe health conditions to regaining independence.
At the heart of Select Medical's business strategy is its ability to monetize diversified segments within healthcare. The company generates revenue through its hospital and outpatient divisions. Long-term acute care hospitals serve patients with critical, acute, and chronic illnesses over extended periods, while inpatient rehabilitation facilities provide intensive therapy and rehabilitation programs. Furthermore, their outpatient rehabilitation clinics offer physical, occupational, and speech therapy to a broader demographic. This multi-faceted approach not only addresses various healthcare needs but also stabilizes revenue streams by reducing dependency on any single segment. By creating a synergy between its service lines, Select Medical positions itself as a comprehensive service provider, maximizing its capability to benefit from the intricate dynamics of the healthcare sector.
Select Medical Holdings Corp. operates in a nuanced and complex healthcare environment, transforming the landscape of rehabilitation and critical illness recovery. Founded in 1996, the company embarked on its journey with a vision to bridge gaps in post-acute care, establishing a network that today includes long-term acute care hospitals, inpatient rehabilitation facilities, and outpatient clinics. This vast network caters to individuals requiring extended medical care, rehabilitation, or therapy following serious illnesses or injuries. The company's operational model revolves around specialized healthcare services, offering a continuum of care that supports patient recovery from severe health conditions to regaining independence.
At the heart of Select Medical's business strategy is its ability to monetize diversified segments within healthcare. The company generates revenue through its hospital and outpatient divisions. Long-term acute care hospitals serve patients with critical, acute, and chronic illnesses over extended periods, while inpatient rehabilitation facilities provide intensive therapy and rehabilitation programs. Furthermore, their outpatient rehabilitation clinics offer physical, occupational, and speech therapy to a broader demographic. This multi-faceted approach not only addresses various healthcare needs but also stabilizes revenue streams by reducing dependency on any single segment. By creating a synergy between its service lines, Select Medical positions itself as a comprehensive service provider, maximizing its capability to benefit from the intricate dynamics of the healthcare sector.
Revenue Growth: Consolidated revenue grew over 7% to $1.36 billion, reflecting strong performance, especially in the inpatient rehab and critical illness segments.
EPS Guidance Raised: Full-year EPS guidance was increased to $1.14–$1.24, while revenue and adjusted EBITDA guidance were reaffirmed.
Regulatory Tailwind: The delay of the CMS 20% transmittal rule resulted in a one-time $12–$15 million EBITDA benefit this quarter and is expected to have a much smaller impact next year.
Outpatient Pressure: The outpatient rehab segment faced margin compression due to Medicare rate cuts and unfavorable payer mix, with EBITDA margin declining to 7.4%.
Active Development: The company continues significant expansion in inpatient rehab, planning to add nearly 400 beds through 2027 and investing in multiple new joint ventures.
Stable Labor Environment: Labor costs are now stable, with agency rates back to pre-COVID levels and overall wage inflation under 3%.
Capital Allocation: The board approved a dividend of $0.0625 per share, and leverage at 3.4x is viewed as comfortable; capital allocation remains opportunistic.